BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1801224)

  • 1. [Pathogenetic role of prolactinemia in multiple sclerosis].
    Golovkin VI; Mikhaĭlenko AA; Rakov AL
    Sov Med; 1991; (10):15-7. PubMed ID: 1801224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of multiple sclerosis with galactorrhea-amenorrhea syndrome].
    Tanaka M; Suzuki T; Endo K; Harayama H
    Rinsho Shinkeigaku; 1997 Jun; 37(6):483-6. PubMed ID: 9366174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between hyperprolactinemia and galactorrhea].
    Romero Gutierrez G; Aguirre Beltran AF; Figueroa Solana MI; Malacara Hernandez JM
    Ginecol Obstet Mex; 1989 Nov; 57():294-7. PubMed ID: 2486966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin level in patients with multiple sclerosis: a case control study.
    Harirchian MH; Sahraian MA; Shirani A
    Med Sci Monit; 2006 Apr; 12(4):CR177-80. PubMed ID: 16572053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous remission in idiopathic hyperprolactinemia.
    Zargar AH; Wani AI; Laway BA; Masoodi SR; Salahuddin M
    J Assoc Physicians India; 1998 May; 46(5):485-6. PubMed ID: 11273299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperprolactinemia and amenorrhea (author's transl)].
    Drobnjak P; Grizelj V; Simunić V
    Lijec Vjesn; 1980 Jun; 102(6):285-94. PubMed ID: 7192792
    [No Abstract]   [Full Text] [Related]  

  • 8. [The value of hyperprolactinemia determination within the scope of galactorrhea].
    Schurz B; Enzelsberger H; Kubista E; Wenzl R
    Zentralbl Gynakol; 1989; 111(1):33-8. PubMed ID: 2493708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolactinemia and ovarian function regulation disorders. I. Amenorrhea-galactorrhea].
    Pérez Peña E; Cabeza de Flores A; Flores Lozano F
    Ginecol Obstet Mex; 1980 Aug; 48(286):69-75. PubMed ID: 7192673
    [No Abstract]   [Full Text] [Related]  

  • 10. [Variations of the plasma levels of gonadotrophins (FSH and LH) and of its response to stimulation with gonadotrophin releasing hormone (GnRH) with different plasma levels of prolactin (PRL) in women with the syndrome of galactorrhea-amenorrhea (author's transl)].
    Salmerón de Diego J; Alonso Rodríguez C; Santos Reyero M; Salazar Orlando A; Palacios Mateos JM
    Med Clin (Barc); 1981 Feb; 76(4):164-8. PubMed ID: 6782394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolactin: estimation and interest in clinical biology (author's transl)].
    Lemaitre BJ
    Ann Biol Clin (Paris); 1980; 38(3):151-6. PubMed ID: 7192521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperprolactinemia--its relation to galactorrhea, amenorrhea, pituitary tumor and its management].
    Ge QS
    Zhonghua Yi Xue Za Zhi; 1984 Sep; 64(9):545-9. PubMed ID: 6442615
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperprolactinemia in relation to galactorrhea and amenorrhea].
    Zhang LZ
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):218-21. PubMed ID: 6426895
    [No Abstract]   [Full Text] [Related]  

  • 14. Galactorrhea, amenorrhea, hyperprolactinemia and pseudotumor cerebri in a patient with primary empty sella syndrome: case report with review of the literature.
    Futterweit W
    Mt Sinai J Med; 1982; 49(6):514-8. PubMed ID: 6984740
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperprolactinemia and primary amenorrhea.
    Kemmann E; Jones JR
    Obstet Gynecol; 1979 Dec; 54(6):692-4. PubMed ID: 514554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients].
    Matveeva TV; D'iakonova IN; Shaĭdullina FS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The physiopathological aspects of the normoprolactinemic amenorrhea-galactorrhea syndrome].
    Porias Cuéllas HL; Hernández Bueno JA; Villanueva C; Benavides S; Cortés-Gallegos V
    Ginecol Obstet Mex; 1987 Feb; 55():53-8. PubMed ID: 3154362
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin and growth hormone responses in the amenorrhea-galactorrhea syndrome.
    Hagen TC; Sill AJ; Garthwaite TL; Halverson G; Borkowf HI
    Obstet Gynecol; 1980 Aug; 56(2):204-7. PubMed ID: 7190256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-induced hyperprolactinemia and galactorrhea].
    Bozzolo M; Haefeli WE; Noll G; Lüscher TF
    Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1511-3. PubMed ID: 1465520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.